Results of clot waveform analysis and thrombin generation test for a plasma‐derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors—phase I trial: 2nd report
暂无分享,去创建一个
Y. Ohashi | J. Takamatsu | A. Shirahata | T. Matsushita | M. Shima | K. Fukutake | S. Higasa | N. Takata | H. Saito | H. Hanabusa | J. Mimaya | M. Sakai | K. Kawakami | H. Takedani | A. Tawa | Y. Takashima
[1] Y. Ohashi,et al. Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.
[2] K. Fischer,et al. Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.
[3] J. Rosing,et al. Thrombin generation tests. , 2011, Thrombosis research.
[4] Y. Nakatomi,et al. Combining FVIIa and FX into a mixture which imparts a unique thrombin generation potential to hemophilic plasma: an in vitro assessment of FVIIa/FX mixture as an alternative bypassing agent. , 2010, Thrombosis research.
[5] Y. Abe,et al. Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[6] K. Mann,et al. Thrombin generation profiles in deep venous thrombosis , 2005, Journal of thrombosis and haemostasis : JTH.
[7] S. Bajaj,et al. The first epidermal growth factor‐like domains of factor Xa and factor IXa are important for the activation of the factor VII–tissue factor complex , 2005, Journal of Thrombosis and Haemostasis.
[8] M. Shima. Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis. , 2004, Seminars in hematology.
[9] Y. Nakatomi,et al. A novel therapeutic approach combining human plasma‐derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone , 2003, Vox sanguinis.
[10] Jean-Luc Pellequer,et al. Model of a Ternary Complex between Activated Factor VII, Tissue Factor and Factor IX , 2002, Thrombosis and Haemostasis.
[11] A. Giles,et al. The Utility of activated Partial Thromboplastin Time (aPTT) Clot Waveform Analysis in the Investigation of Hemophilia A Patients with very Low Levels of Factor VIII Activity (FVIII:C) , 2002, Thrombosis and Haemostasis.
[12] M. Hoffman,et al. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. , 2001, Seminars in hematology.
[13] S. Béguin,et al. The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma , 2000, Thrombosis and Haemostasis.
[14] C. Toh,et al. Early Identification and Prognostic Implications in Disseminated Intravascular Coagulation through Transmittance Waveform Analysis , 1998, Thrombosis and Haemostasis.
[15] J. Oliver,et al. A possible mechanism of action of activated factor VII independent of tissue factor. , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[16] J. Oliver,et al. Platelet activity of high‐dose factor VIIa is independent of tissue factor , 1997, British journal of haematology.